Vallet, France

Hugo Brasselet

This inventor holds 2 USPTO granted patents and 3 published patent applications and 2 EPO patents. Top assignees: Akema France, Arkema France. Active years: 2020.

USPTO Granted Patents = 2 

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Hugo Brasselet

Introduction

Hugo Brasselet is a notable inventor based in Vallet, France. He has made significant contributions to the field of enzymatic processes, particularly in the production of mercaptans and L-methionine. With a total of two patents to his name, Brasselet's work showcases his expertise and innovative spirit.

Latest Patents

Brasselet's latest patents include a method for producing mercaptans by hydrogen-assisted disulfide enzyme hydrogenolysis. This enzymatic process allows for the preparation of a mercaptan of the formula R—SH from disulfides utilizing hydrogen. Additionally, he has developed a method for producing L-methionine, which involves an enzymatic process for preparing L-methionine from diethyl disulfide.

Career Highlights

Throughout his career, Hugo Brasselet has worked with prominent companies such as Arkema France and Akema France. His experience in these organizations has contributed to his development as an inventor and has provided him with valuable insights into the industry.

Collaborations

Brasselet has collaborated with notable individuals in his field, including Georges Fremy and Arnaud Masselin. These partnerships have likely enhanced his research and innovation efforts.

Conclusion

Hugo Brasselet's contributions to enzymatic processes and his innovative patents reflect his dedication to advancing the field. His work continues to influence the industry and showcases the importance of creativity in scientific research.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…